Refresco Beverages US Recall (October 2026): Pur Aqua Sparkling Frost Cherry Limeade

On October 7, 2026, Refresco Beverages US Inc began a Class III recall. Reason: May contain undeclared aspartame.

In plain words

What

Pur Aqua Sparkling Frost Cherry Limeade 17 oz., UPC: 4099100167023

Why

May contain undeclared aspartame.

Where

Florida.

Distribution as reported to FDA: Florida with further downstream distribution to retail stores

How serious

Class III: the FDA uses this class for a situation where eating the product is not likely to cause health problems.

Status: Ongoing. The recall is still in progress.

What to do

Compare the product name, size, UPC and lot or date codes below with what you have. The FDA Enforcement Report is the official record of this recall; for instructions on returns or refunds, follow the notice or contact Refresco Beverages US Inc.

Official notice ↗

The recalled product1

FDA recall H-0095-2027 · Class III · Ongoing

Pur Aqua Sparkling Frost Cherry Limeade 17 oz., UPC: 4099100167023

Codes:
Best if use by: 032327 TA
Quantity:
2100 units

Recall record

Agency
U.S. Food and Drug Administration (FDA)
Recalling firm
Refresco Beverages US Inc, Tampa, FL
Recall started
October 7, 2026
FDA Enforcement Report
October 21, 2026
Initiated
Voluntary: Firm initiated
Recall number
H-0095-2027
FDA event ID
100096

Latest food recalls

JXK Enterprises, Inc is voluntarily recalling Boner Bears Chocolate, Lot #BB21125, after being notified that FDA laboratory analysis confirmed the presence of sildenafil, an active ingredient in the FDA-approved prescription drug Viagra, which is not declared on the product label.

Nationwide · Ongoing

All food recalls

Recall details come from the U.S. Food and Drug Administration's Enforcement Reports (through openFDA) and from USDA's Food Safety and Inspection Service recalls and public health alerts, checked daily. MealSlash shows what the agency published and links every recall to its official notice; the notice is the authority. openFDA's note: do not rely on openFDA to make decisions regarding medical care.